Showing results (1211-1220 of 2,620) with videos related to

Sort By:
Pageof 262
Cirugia Espanola|March 21, 2026
Textbook Outcomes in Pancreatic Surgery: A Systematic Review: Textbook Outcomes en Cirugía Pancreática: una revisión sistemáticaA Sanchez-Mayoral, A Sarriugarte, J Larrea, et al.
Journal of Experimental Marine Biology and Ecology|April 28, 2001
Metabolism and growth of juveniles of Litopenaeus vannamei: effect of salinity and dietary carbohydrate levelsC Rosas, G Cuzon, G Gaxiola, et al.
Health Informatics Journal|January 15, 2021
The effects of a physical activity intervention based on a fatness and fitness smartphone app for University studentsAdrià Muntaner-Mas, Victor A Sanchez-Azanza, Francisco B Ortega, et al.
Journal of Clinical Biochemistry and Nutrition|July 19, 2011
Administration of PPARβ/δ agonist reduces copper-induced liver damage in mice: possible implications in clinical practiceAlvaro A Sanchez-Siles, Norihisa Ishimura, Mohammad A K Rumi, et al.
Journal of Endovascular Surgery : the Official Journal of the International Society for Endovascular Surgery|August 1, 1997
An experimental model for the acute and chronic evaluation of intra-aneurysmal pressureP L Faries, L A Sanchez, M L Marin, et al.
Medicina Intensiva|July 23, 2016
Blood purification in the critically ill patient. Prescription tailored to the indication (including the pediatric patient)J A Sanchez-Izquierdo Riera, R Montoiro Allué, T Tomasa Irriguible, et al.
Frontiers in Microbiology|June 16, 2012
Nitric oxide releasing nanoparticles for treatment of Candida albicans burn infectionsChitralekha Macherla, David A Sanchez, Mohammed S Ahmadi, et al.
Physical Review Letters|August 11, 2005
Two-channel Kondo effect in glasslike ThAsSeT Cichorek, A Sanchez, P Gegenwart, et al.
Archives of Biochemistry and Biophysics|November 23, 2006
Cinnamtannin B-1 from bay wood reduces abnormal intracellular Ca2+ homeostasis and platelet hyperaggregability in type 2 diabetes mellitus patientsA Bouaziz, S Salido, P J Linares-Palomino, et al.
Annals of the Rheumatic Diseases|July 16, 2008
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trialP Emery, E Keystone, H P Tony, et al.
Pageof 262